Meta description: This regulatory style update summarizes an investigational Huntington disease trial using eye tracking and memory testing to explore autobiographical recall and future thought. Publication date February 15, 2026. This report covers an investigational study in Huntington disease that aims to understand autobiographical memory and future thought through eye tracking and neuropsychological testing. The study is listed on ClinicalTrials.gov under identifier NCT07409597 and is sponsored by University Hospital Angers. The trial status is not yet recruiting. This article presents the facts for clinical, quality and regulatory teams evaluating research designs using memory based assessments and eye tracking in Huntington disease.
What is being studied?
The investigational study focuses on autobiographical memory and prospective thinking in individuals with Huntington disease. It uses neuropsychological tests and eye tracking as part of the assessment protocol. The intent is to understand how memory recall and imagined futures relate to eye movements in this patient population, within the constraints of a controlled research setting. The study does not claim outcomes at this stage; it describes the approach and the planned assessments as registered in ClinicalTrials.gov.
Context and aims
Autobiographical memory refers to recollection of personal experiences, while prospective thought involves imagining future events. Huntington disease can affect memory, thought processes, and eye movement patterns. By combining standard neuropsychological assessments with eye tracking, researchers aim to map potential connections between memory function and gaze behavior during memory retrieval and future simulation tasks.
How is the study designed?
The interventions listed include non surgical neuropsychological tests and the use of an eye tracking device during testing. In a regulatory sense the combination of memory based assessments and eye movement recording may support the investigation of cognitive end points in this disease area. The sponsor is University Hospital Angers and the record on ClinicalTrials.gov carries the NCT identifier noted above. The status remains not yet recruiting as of the publication date in the source text.
What devices are used?
The entry specifies the use of an eye tracker, a device category commonly used to measure gaze points and saccades during cognitive tasks. This is not a medical device per se but a research tool that may be used in a device based investigation depending on regulatory context. Manufacturer statements are not included here; the description remains a report of the study design and its stated interventions.
Who is involved and recruitment status?
The sponsor named is University Hospital Angers. The trial status is not yet recruiting. The listing is hosted on ClinicalTrials.gov, a U.S. registry that provides publicly accessible information about interventional and observational studies conducted around the world. The French location and sponsor indicate a cross border or international collaboration in the trial design.
Why it matters to patients and clinicians
For patients and clinicians the outcomes of such studies can influence future research directions. Access to information about trials helps stakeholders understand potential cognitive assessments used with Huntington disease and how eye tracking might support memory research. This article remains informational and does not replace professional medical advice or regulatory guidance.
What are the implications for patients and researchers?
At this stage the trial status not yet recruiting means no results are available. The description indicates the use of eye tracking and neuropsychological tests as part of the research design. Regulatory teams should monitor for updates on recruitment, results, and potential device or software components used in the memory and gaze assessments. The posting on ClinicalTrials.gov provides a stable reference point for stakeholders tracking cross border research in Huntington disease.
FAQ
- 1. What conditions are studied? Huntington disease with emphasis on autobiographical memory and future thought. Answer: The study lists Huntington disease and focuses on autobiographical memory and future thought.
- 2. What methods are used? Neuropsychological tests and eye tracking. Answer: The interventions listed are non surgical neuropsychological tests and the use of an eye tracker.
- 3. Who sponsors the study? University Hospital Angers. Answer: The sponsor is listed as University Hospital Angers.
- 4. What is the recruitment status? Not yet recruiting. Answer: The listing shows Not yet recruiting.
- 5. Where can I find official information? ClinicalTrials.gov listing NCT07409597. Answer: The source link is provided in the article.
Conclusion
This article summarizes an investigational trial in Huntington disease that uses eye tracking and memory based assessments to study autobiographical memory and future thought. The status is Not yet recruiting and no results are available at this stage. Regulatory teams should watch for updates on recruitment status and any changes to the trial design or available endpoints. The information provided here is derived from the ClinicalTrials.gov listing and related sponsor information as of February 2026.
Disclaimer: This information is intended for professionals. It is not legal advice. Regulatory requirements can vary by jurisdiction and over time. It does not replace consultation with regulatory counsel or official guidance from authorities.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07409597?term=medical+device